Schläpfer, Andreas, et al. “The ’Holy Grail’ in Immuno-Oncology: AC BioScience SA Is Aiming to Potentiate Anti-PD-1 Therapy Efficacy through Tumor Cell Conditioning Strategy”. CHIMIA, vol. 74, no. 10, Oct. 2020, p. 771, doi:10.2533/chimia.2020.771.